BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3908568)

  • 1. A simplified method for the preparation of EAC14 intermediate cells using human serum treated with methylprednisolone.
    Kitamura F; Shimada K; Suzuki T; Nishioka K
    J Immunol Methods; 1985 Dec; 85(2):363-70. PubMed ID: 3908568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simplified method for the preparation of EAC14.
    Matre R; Tönder O; Wesenberg F
    J Immunol Methods; 1980; 39(1-2):25-9. PubMed ID: 7007511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New methods for the preparation of the cellular intermediate EAC14.
    Asghar SS; Out J
    J Immunol Methods; 1986 Dec; 95(2):277-81. PubMed ID: 3794347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bovine complement system.
    Linscott WD; Triglia RP
    Adv Exp Med Biol; 1981; 137():413-30. PubMed ID: 7331946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibition of the classical pathway of human complement by polymyxin B.
    Asghar SS; Boot T; van der Helm HJ
    Biochem Pharmacol; 1987 Sep; 36(18):2927-30. PubMed ID: 2820426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of zinc chloride on guinea pig complement component activity in vitro: concentration-dependent inhibition and enhancement.
    Montgomery DW; Chvapil M; Zukoski CF
    Infect Immun; 1979 Feb; 23(2):424-31. PubMed ID: 570556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against components of the classical pathway of complement.
    Heinz HP; Loos M
    Complement Inflamm; 1989; 6(3):166-74. PubMed ID: 2472920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
    Medof ME; Kinoshita T; Nussenzweig V
    J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.
    Goers JW; Porter RR
    Biochem J; 1978 Nov; 175(2):675-84. PubMed ID: 743217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement modulatory activity of bisbenzylisoquinoline alkaloids isolated from Isopyrum thalictroides--I. Influence on classical pathway in human serum.
    Ivanovska N; Nikolova P; Hristova M; Philipov S; Istatkova R
    Int J Immunopharmacol; 1999 May; 21(5):325-36. PubMed ID: 10408629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
    Asghar SS; de Koster A; van der Helm HJ
    Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of bilirubin on complement-mediated hemolysis.
    Arriaga SM; Mottino AD; Almará AM
    Biochim Biophys Acta; 1999 Dec; 1473(2-3):329-36. PubMed ID: 10594370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of complement with the red-cell membrane.
    Rosse WF
    Semin Hematol; 1979 Apr; 16(2):128-39. PubMed ID: 384519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of concanavalin A on the classical complement pathway.
    Langone JJ; Boyle MD; Borsos T
    J Immunol; 1977 May; 118(5):1622-5. PubMed ID: 858916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway.
    Kapil A; Sharma S
    J Pharm Pharmacol; 1994 Nov; 46(11):922-3. PubMed ID: 7897600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade.
    Hong K; Kinoshita T; Miyazaki W; Izawa T; Inoue K
    J Immunol; 1979 Jun; 122(6):2418-23. PubMed ID: 448130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).
    Wilson AB; Prichard-Thomas S; Lachmann PJ; Coombs RR
    Immunology; 1980 Feb; 39(2):195-202. PubMed ID: 7380467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
    Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
    Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.